- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04214262
Test de l'ajout du médicament atezolizumab à la radiothérapie habituelle pour les patients atteints d'un cancer du poumon non à petites cellules précoce
Un essai randomisé de phase III sur l'induction/consolidation de l'atezolizumab (NSC #783608) + SBRT par rapport à la SBRT seule dans le CPNPC à haut risque et à un stade précoce
This phase III trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy, such as stereotactic body radiation therapy, uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving atezolizumab and radiation therapy may work better than radiation therapy alone in treating patients with early non-small cell lung cancer.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
PRIMARY OBJECTIVE:
I. To compare overall survival (OS) in patients with inoperable, early stage non-small cell lung cancer (NSCLC) randomized to stereotactic body radiation therapy (SBRT) with or without atezolizumab.
SECONDARY OBJECTIVES:
I. To compare investigator-assessed progression-free survival (IA-PFS) between the arms.
II. To compare progression free survival (PFS) by blinded independent centralized review (BIRC) between the arms in a random subset of patients.
III. To evaluate distant, locoregional, and local failure rates within each treatment arm.
IV. To evaluate the frequency and severity of toxicities within each treatment arm.
ADDITIONAL OBJECTIVE:
I. To collect specimens for banking.
HEALTH-RELATED QUALITY OF LIFE (HRQOL) OBJECTIVE:
I. This objective will not be met, as the study was closed following the first interim analysis.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients receive atezolizumab intravenously (IV) over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Starting on day 1 cycle 3, patients also undergo SBRT for 3-8 treatments every 2 days or once daily (QD) over 1-3 weeks. Patients undergo fludeoxyglucose F-18 (FDG)-positron emission tomography/computed tomography (PET/CT) during screening. Patients undergo blood sample collection and CT scans throughout the trial.
ARM B: Beginning 21 days after randomization, patients undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial.
After completion of study treatment, patients are followed for 5 years after randomization.
Type d'étude
Inscription (Réel)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
Alaska
-
Anchorage, Alaska, États-Unis, 99508
- Providence Alaska Medical Center
-
-
Arkansas
-
Jonesboro, Arkansas, États-Unis, 72401
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
-
Little Rock, Arkansas, États-Unis, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch, California, États-Unis, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Bakersfield, California, États-Unis, 93301
- AIS Cancer Center at San Joaquin Community Hospital
-
Berkeley, California, États-Unis, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Beverly Hills, California, États-Unis, 90211
- Tower Cancer Research Foundation
-
Dublin, California, États-Unis, 94568
- Kaiser Permanente Dublin
-
Fremont, California, États-Unis, 94538
- Kaiser Permanente-Fremont
-
Fresno, California, États-Unis, 93720
- Kaiser Permanente-Fresno
-
Loma Linda, California, États-Unis, 92354
- Loma Linda University Medical Center
-
Loma Linda, California, États-Unis, 92357
- Veterans Affairs Loma Linda Healthcare System
-
Long Beach, California, États-Unis, 90822
- Tibor Rubin VA Medical Center
-
Los Angeles, California, États-Unis, 90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles, California, États-Unis, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, États-Unis, 90033
- Los Angeles General Medical Center
-
Marysville, California, États-Unis, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, États-Unis, 95355
- Memorial Medical Center
-
Modesto, California, États-Unis, 95356
- Kaiser Permanente-Modesto
-
Oakland, California, États-Unis, 94611
- Kaiser Permanente-Oakland
-
Orange, California, États-Unis, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, États-Unis, 92868
- Saint Joseph Hospital - Orange
-
Palm Springs, California, États-Unis, 92262
- Desert Regional Medical Center
-
Richmond, California, États-Unis, 94801
- Kaiser Permanente-Richmond
-
Roseville, California, États-Unis, 95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville, California, États-Unis, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, États-Unis, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, États-Unis, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, États-Unis, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, États-Unis, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, États-Unis, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, États-Unis, 95823
- Kaiser Permanente-South Sacramento
-
San Francisco, California, États-Unis, 94121
- Veterans Affairs Medical Center - San Francisco
-
San Francisco, California, États-Unis, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, États-Unis, 94115
- California Pacific Medical Center-Pacific Campus
-
San Jose, California, États-Unis, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, États-Unis, 94577
- Kaiser Permanente San Leandro
-
San Rafael, California, États-Unis, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, États-Unis, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, États-Unis, 95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco, California, États-Unis, 94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco, California, États-Unis, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, États-Unis, 95210
- Kaiser Permanente-Stockton
-
Truckee, California, États-Unis, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Vacaville, California, États-Unis, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, États-Unis, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, États-Unis, 94589
- Sutter Solano Medical Center/Cancer Center
-
Walnut Creek, California, États-Unis, 94596
- Kaiser Permanente-Walnut Creek
-
Whittier, California, États-Unis, 90602
- Presbyterian Intercommunity Hospital
-
-
Colorado
-
Aurora, Colorado, États-Unis, 80045
- Rocky Mountain Regional VA Medical Center
-
Aurora, Colorado, États-Unis, 80045
- UCHealth University of Colorado Hospital
-
Colorado Springs, Colorado, États-Unis, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, États-Unis, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, États-Unis, 80920
- Memorial Hospital North
-
Denver, Colorado, États-Unis, 80205
- Kaiser Permanente-Franklin
-
Fort Collins, Colorado, États-Unis, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, États-Unis, 80528
- Cancer Care and Hematology-Fort Collins
-
Greeley, Colorado, États-Unis, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, États-Unis, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, États-Unis, 80129
- UCHealth Highlands Ranch Hospital
-
Lafayette, Colorado, États-Unis, 80026
- Kaiser Permanente-Rock Creek
-
Lone Tree, Colorado, États-Unis, 80124
- Kaiser Permanente-Lone Tree
-
Loveland, Colorado, États-Unis, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, États-Unis, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
-
Connecticut
-
Fairfield, Connecticut, États-Unis, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Greenwich, Connecticut, États-Unis, 06830
- Smilow Cancer Hospital Care Center at Greenwich
-
Guilford, Connecticut, États-Unis, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hamden, Connecticut, États-Unis, 06518
- Smilow Cancer Hospital-Hamden Care Center
-
New Haven, Connecticut, États-Unis, 06520
- Yale University
-
North Haven, Connecticut, États-Unis, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Trumbull, Connecticut, États-Unis, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterford, Connecticut, États-Unis, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Dover, Delaware, États-Unis, 19901
- Bayhealth Hospital Kent Campus
-
Millville, Delaware, États-Unis, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, États-Unis, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, États-Unis, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, États-Unis, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, États-Unis, 20037
- George Washington University Medical Center
-
-
Florida
-
Aventura, Florida, États-Unis, 33180
- GenesisCare USA - Aventura FP
-
Aventura, Florida, États-Unis, 33180
- GenesisCare USA - Aventura
-
Jupiter, Florida, États-Unis, 33458
- Jupiter Medical Center
-
Orlando, Florida, États-Unis, 32806
- Orlando Health Cancer Institute
-
Pembroke Pines, Florida, États-Unis, 33028
- Memorial Hospital West
-
Plantation, Florida, États-Unis, 33324
- GenesisCare USA - Plantation
-
Sarasota, Florida, États-Unis, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, États-Unis, 34232
- Florida Cancer Specialists - Sarasota
-
Sarasota, Florida, États-Unis, 34243
- Sarasota Memorial Health Care Center at University Parkway
-
Sarasota, Florida, États-Unis, 34239
- Florida Cancer Specialists - Sarasota Downtown
-
-
Georgia
-
Augusta, Georgia, États-Unis, 30912
- Augusta University Medical Center
-
Augusta, Georgia, États-Unis, 30901
- Augusta Oncology Associates PC-D'Antignac
-
Savannah, Georgia, États-Unis, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, États-Unis, 31404
- Memorial Health University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, États-Unis, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, États-Unis, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, États-Unis, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, États-Unis, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, États-Unis, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, États-Unis, 96817
- Queen's Cancer Center - Kuakini
-
‘Aiea, Hawaii, États-Unis, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, États-Unis, 96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise, Idaho, États-Unis, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Caldwell, Idaho, États-Unis, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Nampa, Idaho, États-Unis, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
-
Illinois
-
Aurora, Illinois, États-Unis, 60504
- Rush-Copley Medical Center
-
Bloomington, Illinois, États-Unis, 61704
- Illinois CancerCare-Bloomington
-
Bloomington, Illinois, États-Unis, 61701
- OSF Saint Joseph Medical Center
-
Canton, Illinois, États-Unis, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, États-Unis, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, États-Unis, 60612
- University of Illinois
-
Chicago, Illinois, États-Unis, 60612
- Jesse Brown Veterans Affairs Medical Center
-
Decatur, Illinois, États-Unis, 62526
- Decatur Memorial Hospital
-
Effingham, Illinois, États-Unis, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, États-Unis, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, États-Unis, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, États-Unis, 61401
- Illinois CancerCare-Galesburg
-
Kewanee, Illinois, États-Unis, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, États-Unis, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, États-Unis, 60153
- Loyola University Medical Center
-
Ottawa, Illinois, États-Unis, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, États-Unis, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, États-Unis, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, États-Unis, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, États-Unis, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, États-Unis, 61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Peru, Illinois, États-Unis, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, États-Unis, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, États-Unis, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, États-Unis, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, États-Unis, 62702
- Springfield Clinic
-
Springfield, Illinois, États-Unis, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, États-Unis, 61801
- Carle Cancer Center
-
-
Indiana
-
Indianapolis, Indiana, États-Unis, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, États-Unis, 46227
- Community Cancer Center South
-
-
Iowa
-
Ames, Iowa, États-Unis, 50010
- McFarland Clinic - Ames
-
Clive, Iowa, États-Unis, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, États-Unis, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Creston, Iowa, États-Unis, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, États-Unis, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, États-Unis, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
West Des Moines, Iowa, États-Unis, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Wichita, Kansas, États-Unis, 67214
- Ascension Via Christi Hospitals Wichita
-
-
Kentucky
-
Lexington, Kentucky, États-Unis, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
-
Louisiana
-
Baton Rouge, Louisiana, États-Unis, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, États-Unis, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, États-Unis, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, États-Unis, 70808
- Our Lady of the Lake Physician Group
-
Houma, Louisiana, États-Unis, 70360
- Mary Bird Perkins Cancer Center - Houma
-
Houma, Louisiana, États-Unis, 70360
- Terrebonne General Medical Center
-
Metairie, Louisiana, États-Unis, 70006
- East Jefferson General Hospital
-
-
Maryland
-
Towson, Maryland, États-Unis, 21204
- UM Saint Joseph Medical Center
-
-
Massachusetts
-
Beverly, Massachusetts, États-Unis, 01915
- Beverly Hospital
-
Burlington, Massachusetts, États-Unis, 01805
- Lahey Clinic
-
Gloucester, Massachusetts, États-Unis, 01930
- Addison Gilbert Hospital
-
Winchester, Massachusetts, États-Unis, 01890
- Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
-
-
Michigan
-
Ann Arbor, Michigan, États-Unis, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Brighton, Michigan, États-Unis, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, États-Unis, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, États-Unis, 48118
- Chelsea Hospital
-
Clarkston, Michigan, États-Unis, 48346
- Michigan Healthcare Professionals Clarkston
-
Dearborn, Michigan, États-Unis, 48124
- Corewell Health Dearborn Hospital
-
Detroit, Michigan, États-Unis, 48202
- Henry Ford Hospital
-
Detroit, Michigan, États-Unis, 48236
- Henry Ford Health Saint John Hospital
-
Farmington Hills, Michigan, États-Unis, 48334
- Michigan Healthcare Professionals Farmington
-
Farmington Hills, Michigan, États-Unis, 48336
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, États-Unis, 48503
- Genesys Hurley Cancer Institute
-
Kalamazoo, Michigan, États-Unis, 49007
- West Michigan Cancer Center
-
Lansing, Michigan, États-Unis, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, États-Unis, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Macomb, Michigan, États-Unis, 48044
- Michigan Healthcare Professionals Macomb
-
Niles, Michigan, États-Unis, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Novi, Michigan, États-Unis, 48374
- Henry Ford Health Providence Novi Hospital
-
Pontiac, Michigan, États-Unis, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, États-Unis, 48341
- Michigan Healthcare Professionals Pontiac
-
Royal Oak, Michigan, États-Unis, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, États-Unis, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, États-Unis, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, États-Unis, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, États-Unis, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Southfield, Michigan, États-Unis, 48075
- Henry Ford Health Providence Southfield Hospital
-
Tawas City, Michigan, États-Unis, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, États-Unis, 49684
- Munson Medical Center
-
Troy, Michigan, États-Unis, 48098
- Michigan Healthcare Professionals Troy
-
Troy, Michigan, États-Unis, 48085
- Corewell Health Beaumont Troy Hospital
-
Warren, Michigan, États-Unis, 48093
- Henry Ford Health Warren Hospital
-
West Branch, Michigan, États-Unis, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, États-Unis, 49519
- University of Michigan Health - West
-
-
Minnesota
-
Bemidji, Minnesota, États-Unis, 56601
- Sanford Joe Lueken Cancer Center
-
Duluth, Minnesota, États-Unis, 55805
- Miller-Dwan Hospital
-
Minneapolis, Minnesota, États-Unis, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, États-Unis, 55407
- Abbott-Northwestern Hospital
-
Saint Cloud, Minnesota, États-Unis, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Saint Louis Park, Minnesota, États-Unis, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, États-Unis, 55101
- Regions Hospital
-
-
Mississippi
-
Columbus, Mississippi, États-Unis, 39705
- Baptist Memorial Hospital and Cancer Center-Golden Triangle
-
Grenada, Mississippi, États-Unis, 38901
- Baptist Cancer Center-Grenada
-
Jackson, Mississippi, États-Unis, 39216
- University of Mississippi Medical Center
-
New Albany, Mississippi, États-Unis, 38652
- Baptist Memorial Hospital and Cancer Center-Union County
-
Oxford, Mississippi, États-Unis, 38655
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Southhaven, Mississippi, États-Unis, 38671
- Baptist Memorial Hospital and Cancer Center-Desoto
-
-
Missouri
-
Cape Girardeau, Missouri, États-Unis, 63703
- Saint Francis Medical Center
-
Farmington, Missouri, États-Unis, 63640
- Parkland Health Center - Farmington
-
Joplin, Missouri, États-Unis, 64804
- Freeman Health System
-
Kansas City, Missouri, États-Unis, 64128
- Kansas City Veterans Affairs Medical Center
-
Rolla, Missouri, États-Unis, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, États-Unis, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, États-Unis, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, États-Unis, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, États-Unis, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, États-Unis, 63131
- Missouri Baptist Medical Center
-
Sullivan, Missouri, États-Unis, 63080
- Missouri Baptist Sullivan Hospital
-
-
Montana
-
Billings, Montana, États-Unis, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, États-Unis, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, États-Unis, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, États-Unis, 59405
- Benefis Sletten Cancer Institute
-
-
Nebraska
-
Bellevue, Nebraska, États-Unis, 68123
- Nebraska Medicine-Bellevue
-
Grand Island, Nebraska, États-Unis, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, États-Unis, 68847
- CHI Health Good Samaritan
-
Omaha, Nebraska, États-Unis, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, États-Unis, 68118
- Nebraska Medicine-Village Pointe
-
-
New Jersey
-
Basking Ridge, New Jersey, États-Unis, 07920
- Memorial Sloan Kettering Basking Ridge
-
Camden, New Jersey, États-Unis, 08103
- Cooper Hospital University Medical Center
-
Middletown, New Jersey, États-Unis, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, États-Unis, 07645
- Memorial Sloan Kettering Bergen
-
Pennington, New Jersey, États-Unis, 08534
- Capital Health Medical Center-Hopewell
-
Voorhees Township, New Jersey, États-Unis, 08043
- MD Anderson Cancer Center at Cooper-Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, États-Unis, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Brooklyn, New York, États-Unis, 11215
- New York-Presbyterian/Brooklyn Methodist Hospital
-
Buffalo, New York, États-Unis, 14263
- Roswell Park Cancer Institute
-
Commack, New York, États-Unis, 11725
- Memorial Sloan Kettering Commack
-
Cooperstown, New York, États-Unis, 13326
- Mary Imogene Bassett Hospital
-
East Hills, New York, États-Unis, 11548
- The Cancer Institute at Saint Francis Hospital
-
Elmira, New York, États-Unis, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Harrison, New York, États-Unis, 10604
- Memorial Sloan Kettering Westchester
-
Lake Success, New York, États-Unis, 11042
- Northwell Health/Center for Advanced Medicine
-
New York, New York, États-Unis, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, États-Unis, 10019
- Mount Sinai West
-
New York, New York, États-Unis, 10029
- Mount Sinai Hospital
-
New York, New York, États-Unis, 10011
- Mount Sinai Chelsea
-
New York, New York, États-Unis, 10075
- Lenox Hill Hospital
-
New York, New York, États-Unis, 10065
- Manhattan Eye Ear and Throat Hospital
-
Syracuse, New York, États-Unis, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, États-Unis, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, États-Unis, 10467
- Montefiore Medical Center - Moses Campus
-
Uniondale, New York, États-Unis, 11553
- Memorial Sloan Kettering Nassau
-
West Islip, New York, États-Unis, 11795
- Good Samaritan University Hospital
-
-
North Carolina
-
Asheville, North Carolina, États-Unis, 28806
- Messino Cancer Centers
-
Cary, North Carolina, États-Unis, 27518
- UNC Health Cancer Care Cary
-
Charlotte, North Carolina, États-Unis, 28204
- Novant Health Presbyterian Medical Center
-
Durham, North Carolina, États-Unis, 27705
- Durham VA Medical Center
-
Garner, North Carolina, États-Unis, 27529
- UNC Health Cancer Care Garner
-
Gastonia, North Carolina, États-Unis, 28054
- CaroMont Regional Medical Center
-
Hendersonville, North Carolina, États-Unis, 28791
- Margaret R Pardee Memorial Hospital
-
Huntersville, North Carolina, États-Unis, 28078
- Novant Health Cancer Institute - Huntersville
-
Kernersville, North Carolina, États-Unis, 27284
- Novant Health Cancer Institute - Kernersville
-
Matthews, North Carolina, États-Unis, 28105
- Novant Health Cancer Institute - Matthews
-
New Bern, North Carolina, États-Unis, 28561
- CarolinaEast Medical Center
-
Pinehurst, North Carolina, États-Unis, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Raleigh, North Carolina, États-Unis, 27607
- UNC Health Cancer Care Raleigh
-
Raleigh, North Carolina, États-Unis, 27614
- UNC Health Cancer Care Wakefield
-
Supply, North Carolina, États-Unis, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Wilmington, North Carolina, États-Unis, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, États-Unis, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
Winston-Salem, North Carolina, États-Unis, 27103
- Novant Health Forsyth Medical Center
-
-
North Dakota
-
Bismarck, North Dakota, États-Unis, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, États-Unis, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, États-Unis, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Centerville, Ohio, États-Unis, 45459
- Miami Valley Hospital South
-
Chillicothe, Ohio, États-Unis, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, États-Unis, 45220
- Good Samaritan Hospital - Cincinnati
-
Cleveland, Ohio, États-Unis, 44109
- MetroHealth Medical Center
-
Columbus, Ohio, États-Unis, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, États-Unis, 43219
- The Mark H Zangmeister Center
-
Dayton, Ohio, États-Unis, 45409
- Miami Valley Hospital
-
Dayton, Ohio, États-Unis, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, États-Unis, 45409
- Premier Blood and Cancer Center
-
Franklin, Ohio, États-Unis, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Grove City, Ohio, États-Unis, 43123
- Mount Carmel Grove City Hospital
-
Troy, Ohio, États-Unis, 45373
- Upper Valley Medical Center
-
Westerville, Ohio, États-Unis, 43081
- Saint Ann's Hospital
-
Zanesville, Ohio, États-Unis, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Lawton, Oklahoma, États-Unis, 73505
- Cancer Centers of Southwest Oklahoma Research
-
Oklahoma City, Oklahoma, États-Unis, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, États-Unis, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Clackamas, Oregon, États-Unis, 97015
- Clackamas Radiation Oncology Center
-
Gresham, Oregon, États-Unis, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, États-Unis, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, États-Unis, 97213
- Providence Portland Medical Center
-
Portland, Oregon, États-Unis, 97225
- Providence Saint Vincent Medical Center
-
Tualatin, Oregon, États-Unis, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, États-Unis, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Danville, Pennsylvania, États-Unis, 17822
- Geisinger Medical Center
-
Drexel Hill, Pennsylvania, États-Unis, 19026
- Delaware County Memorial Hospital
-
East Stroudsburg, Pennsylvania, États-Unis, 18301
- Pocono Medical Center
-
Hershey, Pennsylvania, États-Unis, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Indiana, Pennsylvania, États-Unis, 15701
- IRMC Cancer Center
-
Lewisburg, Pennsylvania, États-Unis, 17837
- Geisinger Medical Oncology-Lewisburg
-
Monroeville, Pennsylvania, États-Unis, 15146
- UPMC Cancer Center - Monroeville
-
Philadelphia, Pennsylvania, États-Unis, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, États-Unis, 19114
- Jefferson Torresdale Hospital
-
Pittsburgh, Pennsylvania, États-Unis, 15232
- UPMC Hillman Cancer Center
-
Pittsburgh, Pennsylvania, États-Unis, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, États-Unis, 15215
- UPMC-Saint Margaret
-
Pottsville, Pennsylvania, États-Unis, 17901
- Geisinger Cancer Services-Pottsville
-
Selinsgrove, Pennsylvania, États-Unis, 17870
- Geisinger Medical Oncology-Selinsgrove
-
West Reading, Pennsylvania, États-Unis, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, États-Unis, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
Willow Grove, Pennsylvania, États-Unis, 19090
- Asplundh Cancer Pavilion
-
-
Rhode Island
-
Providence, Rhode Island, États-Unis, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Bluffton, South Carolina, États-Unis, 29910
- Saint Joseph's/Candler - Bluffton Campus
-
Florence, South Carolina, États-Unis, 29506
- McLeod Regional Medical Center
-
Gaffney, South Carolina, États-Unis, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, États-Unis, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, États-Unis, 29601
- Saint Francis Hospital
-
Greer, South Carolina, États-Unis, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, États-Unis, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Sioux Falls, South Dakota, États-Unis, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, États-Unis, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Collierville, Tennessee, États-Unis, 38017
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Kingsport, Tennessee, États-Unis, 37660
- Ballad Health Cancer Care - Kingsport
-
Kingsport, Tennessee, États-Unis, 37660
- Wellmont Holston Valley Hospital and Medical Center
-
Memphis, Tennessee, États-Unis, 38120
- Baptist Memorial Hospital and Cancer Center-Memphis
-
-
Texas
-
Conroe, Texas, États-Unis, 77384
- UT MD Anderson - The Woodlands
-
Houston, Texas, États-Unis, 77030
- UT MD Anderson Cancer Center
-
Houston, Texas, États-Unis, 77079
- UT MD Anderson - West Houston
-
League City, Texas, États-Unis, 77573
- UT MD Anderson - League City
-
Sugar Land, Texas, États-Unis, 77478
- UT MD Anderson - Sugar Land
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, États-Unis, 84148
- George E Wahlen Department of Veterans Affairs Medical Center
-
-
Virginia
-
Fairfax, Virginia, États-Unis, 22031
- Inova Schar Cancer Institute
-
Fishersville, Virginia, États-Unis, 22939
- Augusta Health Center for Cancer and Blood Disorders
-
Norton, Virginia, États-Unis, 24273
- Ballad Health Cancer Care - Norton
-
-
Washington
-
Seattle, Washington, États-Unis, 98101
- Virginia Mason Medical Center
-
Vancouver, Washington, États-Unis, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, États-Unis, 98684
- Legacy Cancer Institute Medical Oncology and Day Treatment
-
-
West Virginia
-
Charleston, West Virginia, États-Unis, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
Huntington, West Virginia, États-Unis, 25701
- Edwards Comprehensive Cancer Center
-
Wheeling, West Virginia, États-Unis, 26003
- Wheeling Hospital/Schiffler Cancer Center
-
-
Wisconsin
-
Antigo, Wisconsin, États-Unis, 54409
- Aspirus Cancer Care-Antigo-Volm Cancer Center
-
Appleton, Wisconsin, États-Unis, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, États-Unis, 54915
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
-
Ashland, Wisconsin, États-Unis, 54806
- Northwest Wisconsin Cancer Center
-
Brookfield, Wisconsin, États-Unis, 53045
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
-
Burlington, Wisconsin, États-Unis, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chilton, Wisconsin, États-Unis, 53014
- Ascension Calumet Hospital-Chilton
-
Eau Claire, Wisconsin, États-Unis, 54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire, Wisconsin, États-Unis, 54701
- HSHS Sacred Heart Hospital
-
Franklin, Wisconsin, États-Unis, 53132
- Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
-
Germantown, Wisconsin, États-Unis, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, États-Unis, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, États-Unis, 54311
- Aurora BayCare Medical Center
-
Green Bay, Wisconsin, États-Unis, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, États-Unis, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay, Wisconsin, États-Unis, 54301
- Bellin Memorial Hospital
-
Kenosha, Wisconsin, États-Unis, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, États-Unis, 54601
- Gundersen Lutheran Medical Center
-
La Crosse, Wisconsin, États-Unis, 54601
- Mayo Clinic Health System-Franciscan Healthcare
-
Madison, Wisconsin, États-Unis, 53705
- William S Middleton VA Medical Center
-
Madison, Wisconsin, États-Unis, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marinette, Wisconsin, États-Unis, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, États-Unis, 54449
- Marshfield Medical Center-Marshfield
-
Medford, Wisconsin, États-Unis, 54451
- Aspirus Medford Hospital
-
Mequon, Wisconsin, États-Unis, 53097
- Ascension Columbia Saint Mary's Hospital-Ozaukee Campus-Mequon
-
Milwaukee, Wisconsin, États-Unis, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, États-Unis, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, États-Unis, 53233
- Aurora Sinai Medical Center
-
Milwaukee, Wisconsin, États-Unis, 53211
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus
-
Minocqua, Wisconsin, États-Unis, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, États-Unis, 53149
- ProHealth D N Greenwald Center
-
New London, Wisconsin, États-Unis, 54961
- ThedaCare Cancer Care - New London
-
Oconomowoc, Wisconsin, États-Unis, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, États-Unis, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Oshkosh, Wisconsin, États-Unis, 54904
- Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
-
Racine, Wisconsin, États-Unis, 53406
- Aurora Cancer Care-Racine
-
Racine, Wisconsin, États-Unis, 53405
- Ascension All Saints Hospital-Spring Street-Racine
-
Rhinelander, Wisconsin, États-Unis, 54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake, Wisconsin, États-Unis, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, États-Unis, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Sheboygan, Wisconsin, États-Unis, 53081
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Stevens Point, Wisconsin, États-Unis, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Stevens Point, Wisconsin, États-Unis, 54481
- Aspirus Cancer Care - Stevens Point
-
Sturgeon Bay, Wisconsin, États-Unis, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Summit, Wisconsin, États-Unis, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, États-Unis, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, États-Unis, 53188
- UW Cancer Center at ProHealth Care
-
Wausau, Wisconsin, États-Unis, 54401
- Aspirus Cancer Care-Wausau
-
Wauwatosa, Wisconsin, États-Unis, 53226
- Aurora Cancer Care-Milwaukee West
-
Wauwatosa, Wisconsin, États-Unis, 53226
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
-
West Allis, Wisconsin, États-Unis, 53227
- Aurora West Allis Medical Center
-
Weston, Wisconsin, États-Unis, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, États-Unis, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
-
Patient must have histologically or cytologically proven stage I-IIA or limited T3N0M0 non-small cell lung cancer (NSCLC), without radiographic evidence of nodal or distant involvement (N0M0). Patient may have T3 disease with the exclusion of pericardial involvement. Patients with multifocal tumors with no more than two lesions confirmed or suspected to be synchronous early stage NSCLCs are eligible provided at least one lesion is histologically or cytologically proven to be NSCLC and meets one or more high-risk features
-
Disease must have one or more of the following high-risk features:
- Tumor diameter >= 2 cm (inclusive of any non-solid, ground glass component) as assessed by diagnostic CT
- Tumor standard uptake value (SUV) max >= 6.2 as assessed by FDG PET/CT
- Moderately differentiated, poorly differentiated, or undifferentiated histology
-
Patient must have undergone diagnostic chest CT with or without contrast (IV contrast preferred) within 42 days prior to randomization. PET-CT may be used if the CT portion is of comparable diagnostic quality to a stand-alone CT. All disease must be assessed within 42 days prior to randomization
-
Patient must have undergone FDG PET/CT of chest within 90 days prior to randomization
-
Patient must not have evidence of hilar or mediastinal nodal involvement. Any patient with radiographically suspicious hilar or mediastinal nodes (including features such as non-calcified nodes with a short axis diameter > 1 cm, abnormal morphology, and/or elevated FDG avidity) must undergo cytologic sampling of suspicious nodes to rule out involvement prior to randomization. Mediastinal nodal sampling for other patients is optional. For cases in which the treating physician/multidisciplinary opinion is used to define nodes as "non-suspicious" (such as long-standing, stable enlarged nodes from other medical causes), the rationale must be clearly documented within the medical record
-
Patient must have undergone history and physical examination within 28 days prior to randomization
-
Patient must be medically or surgically inoperable as documented by the evaluating thoracic surgeon or multi-disciplinary tumor board consensus OR patient's unwillingness to undergo surgical resection must be clearly documented
-
Patient must not have received any prior treatment for the current NSCLC diagnosis
-
Patient must not have undergone prior radiation to overlapping regions of the chest that, in the opinion of the treatment physician, will interfere with protocol treatment
-
Patient must not have received treatment with systemic immunostimulatory or immunosuppressive agents, including corticosteroids, within 14 days prior to randomization
-
Patient must be >= 18 years old
-
Patient must have Zubrod performance status of 0-2
-
Patient must have adequate liver function defined as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x institutional upper level of normal (IULN) within 28 days prior to randomization
-
Patient must have adequate renal function defined as calculated creatinine clearance >= 30 mL/min using the following formula. The serum creatinine value used in the calculation must have been collected within 28 days prior to randomization
-
Patient must have absolute neutrophil count (ANC), platelets, and hemoglobin measured within 28 days prior to randomization. The purpose of these tests is to collect baseline values to compare with on-treatment values
-
Patient must have thyroid-stimulating hormone (TSH) measured within 28 days prior to randomization. The purpose of this test is to collect baseline values to compare with on-treatment values
-
Patient must not have significant cardiovascular disease (New York Heart Association [NYHA] class II or greater)
-
Patient must not have myocardial infarction within 90 days prior to randomization
-
Patient must not have unstable arrhythmias or unstable angina
-
Patient must not have known left ventricular ejection fraction (LVEF) < 40% within 28 days prior to randomization
- NOTE: Assessment of LVEF by echocardiogram or multigated acquisition (MUGA) is not an eligibility requirement, but if a standard of care echocardiogram or MUGA was clinically indicated, the LVEF must not be < 40% within 28 days prior to randomization
-
Patient must not have had an infection >= grade 3 (Common Terminology Criteria for Adverse Events [CTCAE] version 5.0) within 28 days prior to randomization
-
Patient must not have an active autoimmune disease that has required systemic treatment in past two years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic treatment and is allowed
-
Patient must be tested for hepatitis B within 28 days prior to randomization. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection. Patients may have past or resolved HBV infection
- Active HBV is defined as having a positive hepatitis B surface antigen (HBsAg) test
- Past or resolved HBV is defined as having a negative HBsAG test and a positive total hepatitis B core antibody (HBcAb) test
-
Patient must be tested for hepatitis C within 28 days prior to randomization. Patient must not have active hepatitis C virus (HCV) infection
- Active HCV is defined as having a positive HCV antibody test followed by a positive HCV ribonucleic acid (RNA) test
-
Patient must have pulmonary function testing to include, at a minimum, forced expiratory volume in 1 second (FEV1) and Diffusing capability of carbon monoxide (DLCO) documented within 90 days prior to randomization
-
Patients with known human immunodeficiency virus (HIV) infection must be receiving anti-retroviral therapy and have an undetectable viral load at their most recent viral load test within 6 months prior to randomization
-
Patient must not have a history of clinically significant interstitial lung disease or evidence of active pneumonitis on the screening chest CT
-
Patients must not have a prior or concurrent malignancy whose natural history or treatment has the potential (in the opinion of the treating physician) to interfere with the safety or efficacy assessment of the investigational regimen
-
Patients must not be pregnant due to the potential teratogenic side effects of the protocol treatment. Women of reproductive potential and men must have agreed to use an effective contraception method for the duration of protocol treatment, and for 5 months (150 days) after the last dose of atezolizumab. A woman is considered to be of "reproductive potential" if she has had a menses at any time in the preceding 12 consecutive months. In addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation. However, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding must be discontinued prior to randomization
-
Patients of reproductive potential must have a negative serum pregnancy test within 14 days prior to randomization
-
Patients must not have known active tuberculosis
-
Patients must not have received a live, attenuated vaccine within 28 days prior to randomization
- NOTE: All coronavirus disease 2019 (COVID-19) vaccines that have received Food and Drug Administration (FDA) approval or FDA emergency use authorization are acceptable
-
Patients must not have a known history of allergic reactions attributed to compounds of similar chemical or biologic composition to atezolizumab
-
Patients must not have a known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric antibodies, fusion proteins, or Chinese hamster ovary cell products or to any component of the atezolizumab formulation
-
Patient must agree to have specimens submitted for translational medicine and banking
-
Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
-
As a part of the OPEN registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
-
Patients who can complete quality of life instruments in English, French, or Spanish must agree to complete the questionnaires at the protocol-specified time points
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm A (atezolizumab, SBRT)
Patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Starting on day 1 cycle 3, patients also undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial. |
Ancillary studies
Autres noms:
Undergo blood sample collection
Autres noms:
Ancillary studies Undergo CT or PET/CT
Autres noms:
Undergo PET/CT
Autres noms:
Given IV
Autres noms:
Undergo FDG PET/CT
Autres noms:
Undergo SBRT
Autres noms:
|
|
Comparateur actif: Arm B (SBRT)
Beginning 21 days after randomization, patients undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial. |
Ancillary studies
Autres noms:
Undergo blood sample collection
Autres noms:
Ancillary studies Undergo CT or PET/CT
Autres noms:
Undergo PET/CT
Autres noms:
Undergo FDG PET/CT
Autres noms:
Undergo SBRT
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Overall Survival
Délai: From date of registration up to two years
|
Count of participants who have died, measured at two years from trial registration. |
From date of registration up to two years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of Adverse Events
Délai: Up to 5 years after registration
|
Only adverse events that are possibly, probably or definitely related to study drug are reported. |
Up to 5 years after registration
|
|
IA-PFS
Délai: From registration up to 5 years
|
Compare investigator-assessed progression-free survival (IA-PFS) between the arms. IA-PFS is defined as 20% increase in the longest diameter of the primary lung tumor over smallest measurement observed using the same techniques as baseline, as well as an absolute increase of at least 0.5 cm, accompanied by confirmatory study (unequivocal PET findings or biopsy) OR appearance of any new lesion/site OR death due to disease without prior documentation of progression OR unequivocal PET findings and/or biopsy confirming malignancy in the absence of growth. |
From registration up to 5 years
|
|
Progression Free Survival
Délai: Up to 5 years from registration
|
Compare PFS (progression free survival) by blinded independent centralized review (BIRC) between the arms in a random subset of patients. PFS is defined as time from date of randomization to date of first documentation of progression assessed by BICR, or death due to any cause. PFS-BICR-1 for patients last known to be alive without report of progression are censored at date of last disease assessment. For patients with a missing scan (or consecutive missing scans) whose subsequent scan determines progression, the expected date of the first missing scan (as defined by the disease assessment schedule) will be used as the date of progression. |
Up to 5 years from registration
|
|
Distant, Locoregional, Local Failure Rates.
Délai: Up to 5 years from registration
|
Evaluate distant, locoregional, and local failure rates within each treatment arm. Treatment failure is defined as time from date of randomization to date of first documentation of investigator-assessed progression or symptomatic deterioration (as defined above), early discontinuation of treatment, or death due to any cause. Time to treatment failure for patients last known not to have failed treatment are censored at the date of last contact. |
Up to 5 years from registration
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Megan E Daly, SWOG Cancer Research Network
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Tumeurs par site
- Tumeurs
- Maladies des voies respiratoires
- Maladies pulmonaires
- Tumeurs des voies respiratoires
- Tumeurs thoraciques
- Carcinome bronchique
- Tumeurs bronchiques
- Tumeurs pulmonaires
- Carcinome pulmonaire non à petites cellules
- Techniques d'investigation
- Thérapeutique
- Techniques de laboratoire clinique
- Techniques et procédures de diagnostic
- Diagnostic
- Procédures chirurgicales, opératoires
- Glucides
- Techniques de chimie, analytique
- Analyse du spectre
- Radiothérapie
- Techniques stéréotaxiques
- Procédures neurochirurgicales
- Désoxyglucose
- Sucres désoxy
- Fluorodésoxyglucose F18
- Manipulation des échantillons
- Spectroscopie de résonance magnétique
- Radiochirurgie
- atézolizumab
Autres numéros d'identification d'étude
- NCI-2019-08627
- U10CA180888 (Subvention/contrat des NIH des États-Unis)
- NCI-2019-08627 (Identificateur de registre: CTRP (Clinical Trial Reporting Program))
- S1914 (Autre identifiant: CTEP)
- S1914 (Autre identifiant: SWOG)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .